About Medicenna Therapeutics Corp. (MDNA) — Dividend Analysis 2026
Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.
Is MDNA a good dividend investment in 2026?
MDNA offers a 1273.89% forward yield with a 50% payout ratio. Strand Safety Score: 15/100 (Critical Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
MDNA DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your MDNA portfolio grows to $2396099932.58M vs $1.28M without reinvestment. This is the compound interest effect in action.
MDNA dividend growth history & forecast
MDNA has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 1273.89%.
Company generates negative FCF ($-13M) — borrowing to pay dividends
Debt Leverage0.0× Debt/EBITDA
0 / 30 pts
0/30
Company not generating EBITDA — debt servicing risk is elevated
Earnings Momentum+0.0B → -0.0B → -0.0B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
High risk of dividend cut — weak fundamentals across multiple factors.
STRAND SCORE
15
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 MDNA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MDNA.
Gross yield
1273.89%
Tax rate
15.00%
After-tax yield
1082.81%
Real yield (−CPI)
1080.01%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
1273.89%
1271.09%
$127,389 / yr
🇺🇸 US Taxable (15%) ✓
15%
1082.81%
1080.01%
$108,281 / yr
🇺🇸 US Taxable (20%)
20%
1019.11%
1016.31%
$101,911 / yr
🇬🇧 UK ISA
0%
1273.89%
1271.09%
$127,389 / yr
🇬🇧 UK Taxable
8.75%
1162.42%
1159.62%
$116,242 / yr
🇨🇦 TFSA
0%
1273.89%
1271.09%
$127,389 / yr
🇨🇦 CA Taxable
25%
955.42%
952.62%
$95,542 / yr
🇦🇺 Super (pension)
15%
1082.81%
1080.01%
$108,281 / yr
🇦🇺 AU Taxable
30%
891.72%
888.92%
$89,172 / yr
🇩🇪 DE Taxable
26.375%
937.90%
935.10%
$93,790 / yr
🇫🇷 FR Taxable
30%
891.72%
888.92%
$89,172 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MDNA Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your MDNA investment of $0.16/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$535947825.62M
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$535947825.62M
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in MDNA for:
Shares needed
14,118
Capital required
$2,217
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MDNA Dividend Payment Schedule
MDNA pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 MDNA vs Healthcare Benchmarks
How MDNA compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+1271.09% vs sectorBetter
MDNA
1273.89%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
MDNA
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
MDNA
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MDNA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MDNA Insider Activity
No recent SEC filings reported in the last 90 days.
🔬
Financial Health Scores
Altman Z-Score
-4.13
🔴 Distress Zone — elevated dividend cut risk
Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81
Piotroski F-Score
1/9
🔴 Weak fundamentals — dividend safety concern
Strong: 7–9 · Moderate: 4–6 · Weak: 0–3
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MDNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →